ArticleActa obstetricia et gynecologica Scandinavica2026
Improved risk stratification for placenta-mediated complications through the use of mid-gestational uterine artery Doppler: A retrospective cohort study.
Article in Acta obstetricia et gynecologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Improved risk stratification for placenta-mediated complications through the use of mid-gestational uterine artery Doppler: A retrospective cohort study.Acta obstetricia et gynecologica Scandinavica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPlacenta-mediated complications such as pre-eclampsia (PE), fetal growth restriction (FGR), and preterm birth (PTB) remain leading causes of maternal and perinatal morbidity. First-trimester screening tools, including the Fetal Medicine Foundation (FMF) algorithm and National Institute for Health and Care Excellence (NICE) criteria, help identify women at risk, but their predictive accuracy remains limited. This study evaluated whether second-trimester uterine artery (UtA) Doppler measurements provided additional risk stratification within risk groups defined by either FMF or NICE-based first-trimester screening. MATERIAL AND
methodsThis was a retrospective cohort study which included 5518 singleton pregnancies managed at University College London Hospital between 2019 and 2022. Women were stratified into four risk groups based on first (1) and second (2) trimester assessments: L1L2 (low risk in both trimesters), L1H2 (low risk in first, high risk in second), H1L2 (high risk in first, low in second), and H1H2 (high risk in both trimesters). First-trimester risk was assessed using FMF or NICE models; second-trimester high risk was defined as a mean UtA pulsatility index (PI) ≥95th centile. Primary outcomes included the incidence of PE, small for gestational age (SGA; birthweight <10th centile), FGR (<3rd centile), PTB before 34 and 37 weeks, stillbirth, and a composite adverse outcome (PE, FGR, PTB, or stillbirth). Secondary outcomes were emergency cesarean section (EMCS), neonatal intensive care unit (NICU) admission, and NICU length of stay. This study was not designed to compare the intrinsic screening performance of NICE and FMF as first-trimester tools.
resultsWomen classified as low risk in the first trimester but high risk in the second trimester had higher rates of adverse outcomes compared to those who remained low risk in both trimesters in both FMF- and NICE-based stratification. Notably, women classified as high risk in both trimesters had the highest rates of placenta-mediated complications, including PE, FGR, PTB, and stillbirth. This pattern was consistent across both first-trimester risk frameworks.
conclusionsMid-gestational UtA Doppler assessment improves prediction of placenta-mediated complications when included with FMF or NICE screening. This two-step approach enhances identification of high-risk pregnancies and supports more personalized antenatal care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.